The Global Pharmaceutical Industry

Research and development (R&D)

USA and European markets

To spread their R&D costs over a larger base

<p>It requires India to enforce product patents by the year 2005 AD</p> Signup and view all the answers

<p>Over 60%</p> Signup and view all the answers

<p>Pharma MNCs are consolidating through mergers and alliances to spread their R&amp;D costs over a larger base.</p> Signup and view all the answers

<p>Under the TRIPs agreement, India has to enforce product patents by the year 2005 AD.</p> Signup and view all the answers

<p>Over 60% of the drugs/formulations in the Indian pharma sector are Government controlled through DPCO.</p> Signup and view all the answers

<p>The high prices of under-patent drugs are causing a shift to generics in the USA and European markets.</p> Signup and view all the answers

<p>Major players are focusing on formulations where brand image and distribution network act as entry barriers.</p> Signup and view all the answers